Endocrine Abstracts (2015) 37 EP820 | DOI: 10.1530/endoabs.37.EP820

High BMI in female patients with prolactinomas

Irena Ilovayskaya, Alexander Dreval, Yulia Krivosheeva, Irina Chikh & Galina Stashuk


Moscow Regional Research and Clinical Institute N.A. M.F. Vladimirskiy, Moscow, Russia.


We analysed BMI of 270 female patients: 148 with hyperprolactinaemia (non-tumoural hyperprolactinaemia, n=46; microadenomas, n=56; and macroadenomas, n=46), 55 with isolated central hypogonadism, 67 with hypopituitarism. Additionally, 53 healthy women of reproductive age and 51 postmenopausal women were examined. In patients with hyperprolactinaemia median prolactin levels were 1547 (1124; 2185), 1490 (1050; 2280), and 3100 (1790; 18840) mE/l, accordingly (P=0.002). Median BMI in hyperprolactinaemic women was elevated (25 (23; 34.5) kg/m2) but this parameter varied in dependence of hyperprolactinaemia type: BMI was 22.5 (20; 23) kg/m2 in non-tumoural hyperprolactinaemia, 23 (22; 34.5) kg/m2 – in microprolactinomas and 32 (26; 35) kg/m2 – in macroprolactinomas (P=0.023). There was no significant correlation between BMI and prolactin levels; however, there was a positive correlation between BMI and prolactinoma volume (r=0.49, P=0.015). BMI in women with nontumoral hyperprolactinaemia did not differ from healthy women (21 (20; 23.5) kg/m2, P=0.8) and women with isolated central hypogonadism (22.2 (20; 23.8) kg/m2, P=0.6). BMI in women with microprolactinomas was significantly higher than in healthy women and in non-tumoral hyperprolactinaemia (P=0.03) however was comparable with hypopituitary patients (24 (22.7; 27.3) kg/m2, P=0.33) and postmenopausal women (24.4 (23.2; 27.1) kg/m2, P=0.35). The highest BMI was noted in patients with macroprolactinomas and it was significantly greater than BMI in other hyperprolactinaemic and non-hyperprolactinaemic subgroups (P<0.001 for all). Thus, we conclude that hyperprolactinaemia per se is not a risk factor for obesity in women. Prolactin-secreting pituitary lesions lead to the higher rate of increased BMI, and macroprolactinomas are more powerful risk factor for obesity than physiological menopause or hypopituitarism.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts